Truly Labs presented, together with Dept. Translational Medicine, Medical Radiation Physics, a poster at ERS in Paris. The poster describes our work with in vivo models of drug induced ILD. The work is being done within the TRISTAN-IMI consortium and aims to find better tools to study and improve drug safety using imaging biomarkers.
In vivo models designed to study and improve drug safety by using imaging biomarkers
To address the increasing issue of drug-induced toxicity, both clinical and pre-clinical studies (within our EU-IMI funded project TRISTAN) are aiming to find translational Imaging Biomarkers that can indicate progression of drug-induced injury at an early stage. Various imaging techniques such as MRI, PET and CT are used in association to todays established analysis methods such as histology, cell- and protein analyses.
Link to IMI-TRISTAN home page
Click image above to view poster